(Q40082035)

17 September 2017

title

A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging (English)

1 reference

17 September 2017

0 references

1 reference

Boris A Hadaschik

1

0 references

author name string

Peter C Black

2

1 reference

17 September 2017

Jason C Sea

3

1 reference

17 September 2017

Adam R Metwalli

4

1 reference

17 September 2017

Ladan Fazli

5

1 reference

17 September 2017

Colin P Dinney

6

1 reference

17 September 2017

Martin E Gleave

7

1 reference

17 September 2017

Alan I So

8

1 reference

17 September 2017

publication date

10 September 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

100

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

1377-1384

1 reference

Bladder cancer: epidemiology, staging and grading, and diagnosis.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

The treated natural history of high risk superficial bladder cancer: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Advances in imaging mouse tumour models in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Oncolytic viral therapy by bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07165.X

10.1111/J.1464-410X.2007.07165.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference